Skip to main content
. 2018 Oct 9;12:697. doi: 10.3389/fnins.2018.00697

Table 2.

Activin A targets in brain injury.

activin A-related brain injury Targets/mechanism References
Hypoxic-ischemic brain damage Follistatin/BMP-4,
Act A/Smad pathway,
p-Smad3/CHOP/caspase-12,
LC3II/Beclin1,
JNK1/p38
Tian et al., 2014
Nakajima et al., 2014
Guo et al., 2014
Wang et al., 2016a
Xue et al., 2017.
Focal cerebral ischemia Act A/Smad pathway Mukerji et al., 2009
Hiratochi et al., 2007
Xue et al., 2016.
Ischemic tolerance Act RII/JNK1/Smad3/Smad4 Xue et al., 2016
Wang et al., 2016b.
Cerebral hemorrhage activin A binding protein Nicolas et al., 2017
Ebert et al., 2006.
Premature infant brain injury Acvr2a/Acvr2b,
IL-10
Dillenburg et al., 2018
González-Domínguez et al., 2016
Petrakou et al., 2013.
Sepsis encephalopathy TNF-α/IL-6/IL-1,
caspase-1/IL-1β/ IL-8
Tania et al., 2014
Petrakou et al., 2013
Asashima et al., 1991.

Act A, activin A; Act RII, activin A receptor type II; Acvr2a/Acvr2b, activin A receptor type 2a/2b; BMP-4, bone morphogenetic protein 4; CHOP, C/EBP homologous protein; IL, interleukin; JNK1, c-Jun N-terminal kinase 1; LC3II, microtubule-associated protein light chain 3 II; TNF-α, tumor necrosis factor alpha.